Finally, we validated five of the ten genes (C1QA, C3AR1, LCP2, SPI1 and TYROBP) as independently associated with poor survival and tightly related with M2 macrophage surface biomarkers, which may provide new therapeutic avenue for ESCC. Here, TYROBP is linked to esophageal squamous cell carcinoma.